undefined undefined
NaN.000
NaN.00%
Robert W. Baird analyst Jack Allen has maintained their bullish stance on VOR s...
05-14 16:47
Vor Biopharma press release (NASDAQ:VOR): Q1 GAAP EPS of $0.45. Cash, cash equivalents and marketable securities were $107.5 million as of March 31, 2024, More on Vor Biopharma Seeking Alpha’s Quant R...
05-10 19:20
Vor Biopharma (VOR) has shared an update. Vor Biopharma Inc. has expanded its B...
05-03 04:27
Wedbush:重申Vor Biopharma(VOR.US)评级,由优于大市调整至优于大市评级, 目标价11.00美元。
04-24 01:30
Gainers: Masimo (MASI) +12%. Pliant Therapeutics (PLRX) +5%. Vor Biopharma (VOR) +5%. Vor Biopharma (CNDT) +4%. Xometry (XMTR) +4%. Losers: Airship AI Holdings (AISP) -7%. Canopy Growth (CGC) -4%. Cal...
03-23 04:59
CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a cl...
2023-10-04 04:01
JMP Securities analyst Silvan Tuerkcan reiterates Vor Biopharma (NASDAQ:VOR) with a Market Outperform and maintains $12 price target.
2023-08-14 20:52
What is the target price for Vor Biopharma (VOR)?The latest price target for Vo...
2023-08-11 06:32
On Thursday, 109 companies set new 52-week lows.
2023-07-07 00:58
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
2023-07-05 20:51